News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
122 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4450)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (5)
2 (321)
3 (345)
4 (310)
5 (394)
6 (122)
7 (3)
8 (3)
9 (242)
10 (360)
11 (259)
12 (398)
13 (145)
14 (4)
15 (16)
16 (326)
17 (318)
18 (251)
19 (262)
20 (127)
21 (4)
22 (5)
23 (228)
24 (302)
25 (222)
26 (289)
27 (144)
28 (1)
29 (3)
30 (42)
31 (252)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Ocugen Provides Business Update and First Quarter 2022 Financial Results
Ocugen, Inc. reported first quarter 2022 financial results along with a general business update.
May 6, 2022
·
10 min read
Ductless Fume Hoods Market: The hospitals & diagnostic laboratories segment is projected to expand at the maximum growth rate
Albany NY, United States: Ductless fume hoods, also called filtered fume hoods, are self-contained and filtered laboratory workstations that remove hazardous chemical fumes, particles, and vapors from the laboratory environment.
May 6, 2022
·
6 min read
Beta-Lactam Drugs Market: Increase in prevalence of infectious diseases such as MRSA to drive the market
Albany NY, United States: Beta-lactams are antibacterial drugs that possess the basic characteristic of inhibition of bacterial cell wall synthesis.
May 6, 2022
·
6 min read
Intra-abdominal Infections Market: Growing incidence of infectious and chronic diseases to drive the market
Albany NY, United States: The intra-abdominal infection indicates inflammation of a single organ in the entire intra-abdominal area or peritonitis.
May 6, 2022
·
6 min read
Global Healthcare CRM Market Growth at a CAGR of 14.6% during the forecast period of 2018 to 2023
The global healthcare CRM market is projected to register growth at a CAGR of 14.6% during the forecast period of 2018 to 2023 and gain a valuation of US$ 17.4 Bn by 2023.
May 6, 2022
·
8 min read
Electronic Stethoscope Market expected to reach US$ 369 Mn by 2029 - Comprehensive Research Report by FMI
DUBAI, United Arab Emirates, Global Electronic Stethoscope Market was valued at US$ 170.9 Mn in 2021 and the sales are expected to surpass US$ 259 Mn, increasing by 2.2x between 2022 and 2029.
May 6, 2022
·
6 min read
Swine Flu Vaccine Market: Rising awareness about influenza A to drive the market
Albany NY, United States: Swine flu is infection of the respiratory system caused by influenza viruses.
May 6, 2022
·
6 min read
Protease Inhibitors Market: The Protease Inhibitor Drugs Segment is Expected Hold a Significant Share of the Global Market
Albany NY, United States: The ‘protease inhibitor’ are molecules which have many different applications.
May 6, 2022
·
5 min read
Relief Therapeutics Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding SA
RELIEF THERAPEUTICS Holding SA, a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, gives notice of the Annual General Meeting of shareholders to be held on May 31, 2022.
May 6, 2022
·
5 min read
Orion enters into exclusive agreement with Jemincare for novel non-opioid drug candidate for the treatment of pain
Orion Corporation has entered into an agreement with Chinese Jemincare, through which Orion will receive exclusive global development and commersialisation rights, excluding the Greater China area, for a potent and selective NaV 1.8 blocker for the treatment of acute and chronic pain.
May 6, 2022
·
4 min read
Previous
3 of 13
Next